Have a target of around 360 on Glenmark: Hemant Kale, Maia Financial Services

Hemant Kale, MD, Maia Financial Services, in a chat with ET Now talks about Glenmark.

What is your take on Glenmark?

One of the stocks I would like to recommend in pharma space is Glenmark. This stock has given a long term consolidation breakout last week. On the short term, it is experiencing some weakness and this weakness could probably be used as an opportunity to enter into this stock. Keep a stop loss of 295 and have a target of around 360 levels.